ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1649

Effect of Knee Aspiration and Intra-articular Corticosteroid Injection on Gait Biomechanics and Strength Impairment in Patients with Signs of Inflammation Due to Knee Osteoarthritis

Ryan Pinto1, Trevor Birmingham1, Holly Philpott2, Dominique Arsenault1, Codie Primeau1 and Tom Appleton3, 1Western University, London, Canada, 2Western University, London, ON, Canada, 3The University of Western Ontario, LONDON, ON, Canada

Meeting: ACR Convergence 2020

Keywords: gait, Inflammation, Osteoarthritis, Ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2020

Title: Osteoarthritis – Clinical Poster II

Session Type: Poster Session D

Session Time: 9:00AM-11:00AM

Background/Purpose: Synovial inflammation in knees with OA can be measured with musculoskeletal ultrasound (MSK US), is associated with increased pain and disease progression, and may adversely affect joint biomechanics. Knee effusion has been associated with quadriceps avoidance gait (decreased external knee flexion moment (KFM) during walking, altered quadriceps and hamstring activation) in patients with knee OA, however, the effect of treating knee inflammation on gait biomechanics and strength is unknown. The purposes of this study were to: 1) investigate the effects of treating knee inflammation on gait biomechanics, strength and patient-reported outcomes in patients with knee OA and inflammation, and 2) explore the associations between these measures.

Methods: 72 knees from 51 patients with knee OA and signs of moderate synovitis and effusion on MSK US underwent bilateral gait biomechanics, strength and US assessments, and completed knee-specific numeric rating scales (NRS) for pain and Knee Injury and Osteoarthritis Outcome Scores (KOOS) before and 3 weeks after receiving an US-guided knee aspiration and injection of 40 mg triamcinolone acetonide. Three-dimensional quantitative gait analysis was completed using a 12-camera motion capture system and floor-mounted force plate to calculate knee angles and moments, with the peak external KFM as the primary outcome. Knee extension and flexion strength (peak torque in Nm) was tested using an isokinetic dynamometer (90o/s). US assessments were performed using a linear 3-12 MHz probe. The suprapatellar recess was scanned in the long axis view (medial, lateral, midline) with the knee flexed to 20o. All US exams were graded using the OMERACT system for inflammatory features of knee OA. Paired T-tests were used to determine mean changes and 95% confidence intervals from pre to 3 weeks post injection for all measures. Mixed effects regression with robust sandwich estimators was then used to evaluate the associations between potential predictors and peak KFM during walking. Random intercepts and slopes were specified by patient ID, time and limb. Potential predictors included US regional score (0-9), effusion depth (mm), gait speed (m/s), NRS (0-10), and quadriceps strength (Nm). Only knees undergoing aspiration and injection were evaluated.

Results: Baseline demographic and clinical characteristics are presented in Table 1. US regional score, effusion depth and NRS pain decreased post injection (Table 2). The peak KFM during walking, quadriceps and hamstring strength and KOOS subscales (symptoms, pain, daily living) increased post injection (Table 2). While controlling for time and limb, increases in gait speed and reductions in NRS pain were associated with greater peak KFM (Table 3).

Conclusion: Aspiration and corticosteroid injection improves signs of inflammation on MSK US, gait biomechanics associated with quadriceps avoidance gait, strength, and patient-reported measures of pain and function in patients with knee OA. Greater gait speed and lesser knee pain were associated with less quadriceps avoidance gait. This suggests that local knee inflammation may contribute to abnormal gait biomechanics, however, further research is needed to understand the mechanism.

Table 1. Demographic and clinical characteristics (n=51 patients, 72 knees)

Table 2. Descriptive statistics for outcome measures pre and 3 weeks post injection.

Table 3. Linear mixed effects model estimates


Disclosure: R. Pinto, None; T. Birmingham, None; H. Philpott, None; D. Arsenault, None; C. Primeau, None; T. Appleton, Abbvie, 2, 5, 8, CaRE Arthritis, 2, Gilead, 2, 5, 8, Pfizer, 2, 5, 8, Servier/Galapagos, 2, Amgen, 5, 8, BMS, 5, 8, Celgene, 5, 8, Janssen, 5, 8, Merck, 5, 8, Novartis, 5, 8, Hoffman LaRO=oche, 5, 8, Sandoz, 5, 8, Sanofi-Genzyme, 5, 8, UCB, 5, 8, Ontario Rheumatology Association, 6, Canadian Rheumatology Association, 6, American College of Rheumatology, 6.

To cite this abstract in AMA style:

Pinto R, Birmingham T, Philpott H, Arsenault D, Primeau C, Appleton T. Effect of Knee Aspiration and Intra-articular Corticosteroid Injection on Gait Biomechanics and Strength Impairment in Patients with Signs of Inflammation Due to Knee Osteoarthritis [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/effect-of-knee-aspiration-and-intra-articular-corticosteroid-injection-on-gait-biomechanics-and-strength-impairment-in-patients-with-signs-of-inflammation-due-to-knee-osteoarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/effect-of-knee-aspiration-and-intra-articular-corticosteroid-injection-on-gait-biomechanics-and-strength-impairment-in-patients-with-signs-of-inflammation-due-to-knee-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology